|
WOMEN'S MEDICAL ISSUES, WOMEN'S HEALTH
|
HRT concise summary--jk
|
|
|
Natural HRT Benefits; Mare’s urine estrogen with MPA, the tragic
differences (10/13/12)--jk
The reason why women’s health precipitously
declines after menopause
The
long-term use of NATURAL estradiol (estrogen) and progesterone has been shown
to DECREASE the risk of: Alzheimer’s 83%, Heart attacks
32%, Coronary Heart Disease 50%, Colorectal Cancer 46%, Breast Cancer 0%, Thrombosis
8%,, Osteoporosis Fractures 90%, Macular degeneration 65%, reduces &
prevents arthritic join destruction, firmer breasts, Healthier skin
(less wrinkles, thicker, 48% more collagen), reduces hair loss, improves
cognitive function, less depression and mental illness, and a general
feeling of well-being with increased libido. These claims are referenced
below and at http://healthfully.org/fhr/.
Backdrop: 1) The Pharmaceutical industry (hereafter
referred to by their trade organization PhARMA) is about profit
maximization; public service is their hype.
2) What
follows assumes that you have read the 2-page account of the
state of “Marketing Science and Misinformation”. In that paper you will
find out that PhARMA totally dominates medicine:
research, the production of
information for physicians and the public, the setting up of treatment
protocols, and the FDA from the top- down. Money
talks: the medical journals and media
are “PhARMA friendly, as is also our 2-party system.
Estrogen
Basics: Estrogens are a group of compounds named for their importance
in the estrous cycle of humans and other animals. They are
the primary female sex hormones. Natural
estrogens are steroid hormones, while some synthetic ones are
non-steroidal. The name comes from the Greek
οἶστρος (oistros), literally meaning "gadfly" but figuratively
sexual passion or desire,[1] and
the suffix -gen,
meaning "producer of".
Estrogens are synthesized in all vertebrates[2]
as well as some insects.[3] Like all steroid hormones, estrogens readily diffuse
across the cell membrane. Once inside the cell, they bind to and
activate estrogen receptors which in turn modulate the expression
of many genes.[4]
Additionally, estrogens have been shown to activate a G protein-coupled receptor, GPR30.[5] The three
major naturally occurring estrogens in women are estrone (E1), estradiol
(E2), and estriol
(E3). Estradiol (E2) is the predominant estrogen during reproductive
years both in terms of absolute serum levels as well as in terms of estrogenic
activity. Estradiol is about 10 times as
potent as estrone and about 80 times as potent as estriol in its estrogenic
effect. Estrone is secreted by the
ovary, adipose [fat] tissue, and placenta.
As a sulfate it acts as a reservoir that can be converted as needed to
estradiol. During menopause, estrone is
the predominant circulating estrogen. Estriol during pregnancy is the
predominant circulating estrogen in terms of serum levels. Though
estriol is the most plentiful of the three estrogens it is also the weakest. Thus, estradiol is the most important
estrogen in non-pregnant females who are between the menarche and menopause
stages of life. A 4th type of estrogen
called estetrol
(E4) is produced only during pregnancy.
All of the different forms of estrogen are synthesized from androgens,
specifically testosterone and androstenedione,
by the enzyme aromatase. Follicle-stimulating hormone (FSH)
stimulates the ovarian production of estrogens by the granulosa
cells of the ovarian follicles and corpora
lutea. Some estrogens are also
produced in smaller amounts by other tissues such as the liver, adrenal
glands, and the breasts. Androstenedione has weak androgenic activity
[muscle building] and is the predominant precursor for the more potent androgens
such as testosterone as well as estrogen.
Among estrogen’s over 2-dozen bodily functions are those of lowering the
remodeling threshold, thus preventing osteoporosis. Estrogen prevents cardiovascular disease by lowering
cholesterol levels,
and by reducing inflammation and oxidative
damage to VLD [bad cholesterol]. Inflammation
and oxidative damage are causal factors for cognitive decline, Alzheimer’s
disease and other conditions. Estrogens
circulate in the blood in association with proteins including sex hormone
binding globulin and albumin (50-80%), and a significant portion is in the form
of a sulfate. It is distributed in most
tissues, especially the breast, uterine, vaginal, and has a high affinity of
adipose tissue. Estrogens are
metabolized in the liver and excreted as metabolites by the kidney. Estradiol during menopause sharply declines; but
the levels of total and free testosterone, as well as dehydroepiandrosterone sulfate
(DHEAS) and androstenedione appear to decline gradually with age.
The limited effectiveness of plant type estrogens is due to their lower
bio-activity and first-pass metabolism by the liver. Progesterone belongs to a class of hormones called progestogens,
and is the major naturally occurring human progestogen. The recognition of
progesterone's ability to suppress ovulation
during pregnancy spawned a search for a similar hormone that could bypass the
problems associated with administering progesterone (low bioavailability when
administered orally and local irritation and pain when applied to the skin). A progestin is a synthetic[1]
progestogen
that has progestational effects similar to progesterone.[2]
The two most common uses of progestins are for hormonal contraception (either alone or with
an estrogen),
and to prevent endometrial hyperplasia [excess tissue in
the uterus] from unopposed estrogen in hormone replacement therapy. [Progestins is in HRT to lower the risk of uterine cancer.] In mammals, progesterone, like
all other steroid hormones, is
synthesized from pregnenolone, which in turn is derived from cholesterol
in a very complex bio-system (Wikipedia). Synthetic plant and horse estrogens are
inferior to evolved human natural hormones.
The synthetics progestin MPA in Prempro HRT is much worse than
progesterone. As for other synthetic
progestins, little is known about their side effects. What follows is setting the record straight
by distinguishing natural versus Prempro, then list of journal links to
estrogen’s benefits.
Bad Press: Prempro, one of the first HRTs, has
been marketed since 1942 by Wyeth Laboratory (bought out by Pfizer in 2009). It has been and still is the best-selling
HRT. A supposedly definitive study of HRT was done by the FDA’s drug
research branch, National Institute of Health (NIH) (with
undoubtedly a nod from PhARMA). The Women’s
Health Initiative (WHI)
knowingly selected the worst formulation
of HRT, Prempro . NIH had the results of the Hormone Estrogen Replacement Study
(HERS
) completed in 1998 used Prempro; moreover,
the medical literature had numerous disappointing results for Prempro when compared
to natural HRT formulas. Prempro
consists of an estrogen cocktail derived from pregnant mare’s urine to which is added the synthetic progestogen
MPA.
(The tragic treatment and slaughter produced from collecting urine for
estrogen was broadcast
by Frontline.) “Pregnant mare’s estrogens are the weak estrone
(>50%), and the two mare estrogens, equilin (15-25%)
and equilenin…. It is not clear if estrogens such as equilin,
that are foreign to the human body, likely have effects that are significantly
different from the human estrogens like estradiol. MPA, the
synthetic progestin used in Prempro, blocks
most of the beneficial effects of estrogen--the natural progesterone
doesn’t. Using Prempro, the WHI found that compared to a
placebo there was increased incidents: heart
attacks 29%, breast cancer 26%, pulmonary embolism 113%, strokes 41%, total
deaths 15%, all cancers 3%; reduced incidents: hip fractures 34% and colon cancer 37%. (Compare this to
the benefits of natural
estradiol with progesterone listed at the top of the first page.) The press made the most of these results
(undoubtedly with a nod from their biggest advertiser). HRT sales plummeted with this assault. The estrogen only arm of WHI had better results; more proof that
adding MPA causes the harm. But equine (horse) estrogen is clearly inferior to estradiol in other studies.
Pfizer in 2010 settled a
suit over breast cancer for $330 million or $150,000 per person. Yet Prempro is still on the market (thank you
FDA) and still first in sales. The NIH along with PhARMA deliberately
failed to distinguish the natural HRT from Prempro. Based on the WHI, NIH issued this
warning: “…increased risk of myocardial infraction, stroke, invasive breast
cancer, pulmonary emboli, and deep vein thrombosis in postmenopausal women… Estrogens with or without progestins should
be prescribed at the lowest effective doses and for the shortest duration
consistent with treatment goals and risks for the individual woman”. The warning is placed on all packages
of HRT—not just Prempro. I suspected the worst of NIH and PhARMA having followed in the journals HRT and
the birth
control pill since the early 70s. My
doubts were confirmed when attending a lecture in 2002 given at UCSD by Professor
Robert Langer. He explained to a large
medical audience that the WHI results can only be validly applied to
Prempro. Over 50 years of research were
not overturned; but physicians and the public were tragically misled by the
press, PhARMA, and the NIH
|
|
^^^^^^^ Setting the
record straight findings for natural HRT -- see also http://healthfully.org/fhr/
^^^^^^^^^
Set Up to Fail was published in the
highly acclaimed science journal, Nature, 09/09/2010: “Prempro contains no progesterone, but
instead the artificial progestogen Provera [MPA]. The other component is Premarin
(conjugated estrogen), which is a very uncertain, patent mixture of substances
from the urine of pregnant mares…. [MPA] has crucially different effects. Prempro
is totally unrepresentative of any other product used for HRT purposes…. . Much of it was known
before the NIH chose to use Prempro in its intended landmark study. Using a study of the effects of Prempro to attack the entire use
of HRT has, through needless
fear, caused millions of women to forgo considerable benefits of HRT using
better products. This point has been
repeatedly made by endocrinologists”.
"I think that it borders on a tragedy
that Premarin and
Provera [the 2 compounds in Prempro] were chosen as the only HRT treatments
[for the WHI Study]”. Another researcher
finds that Provera [MPA]--and no other progestin--blocks the mechanisms that
allow estrogen to fight the brain's immune response to Alzheimer's…. Neuroendocrinologist
Bruce S. McEwen of the Rockefeller University is unequivocally critical of the
study: "I think that it borders on a tragedy that Premarin and Provera
were chosen as the only HRT treatments."
“Medroxyprogesterone [MPA] in Provera you are activating two receptors
involved with cell
division in the breast," she says, "and that's the culprit, not
estrogen [for increased breast cancer]." In addition, recent research shows that Provera interferes with estrogen's ability to prevent
memory loss
and dementia. "Estrogen is able to protect neurons
against toxic assaults
that are associated with Alzheimer's disease," notes Roberta Diaz Brinton,
a neuroscientist at the University of Southern California…. she found “that
Provera--and no other progestin--blocks the mechanisms that allow estrogen to
fight the brain's immune response to Alzheimer's”. This immune
response wears away at brain cells and causes them to leak neurotransmitters
such as glutamate, which overloads and kills neurons.” Hormone
Hysteria, Scientific American Sept. 2003.
Cardiovascular disease (CVD)
“Women lose their relative protection … 14% higher total
cholesterol, 12% higher triglycerides, and 27% higher LDL cholesterol; 7% lower
HDL…. Estrogen-replacement therapy has been shown to decrease CAD morbidity and
CAD mortality …. In a meta-analysis … the relative risk for CAD in
postmenopausal subjects taking estrogen was 0.56 compared with postmenopausal
subjects not taking estrogen”.
Braunwald, Heart Disease: a
Textbook of Cardiovascular Medicine 5th Ed.1997 p 1142”. That is a 44% reduction--another study
found
a 50% reduction in CHD after HRT; its mechanism. CVD is the number one cause of death. Another found 56 deaths
vs. 26 for placebo
Breast cancer: No increased of risk: “The association of estrogen-progestogen
combinations with breast cancer risk varied significantly according to the type
of progestogen: the relative risk was 1.00 (0.83–1.22) for estrogen–progesterone [all natural, also in and].” The same is
mention in the Scientific American article above.
Colon cancer: “the
reduction among current users RR = 0.55… users of 11 years or more RR of
0.54 [46% lower, also].” Benefits found for
“esophagus, stomach, peptic ulcer disease,
gallbladder, irritable bowel syndrome,
colon,” etc.
Alzheimer’s disease reduced 83% with long-term HRT. This is
because estrogen is neuro-protective,
it inhibits
oxidative damage. Progesterone
also limits damage and is used in a large dose following trauma “to limit
central nervous system
damage.”
Thrombosis: an 8% reduction in
risk of with Esterfied Estrogen while those on Prempro had a 65% elevated risk JAMA 04, “Cases and controls, whose average age
was 65 years, did not differ significantly on matching variables or on current
use of exogenous
estrogen (5.1% of cases versus 6.3% of controls).” A 23% reduction with estrogen is significant!
Breast density measured for women on HRT. The difference has been repeatedly
noted on mammograms.
Healthier
skin American Journal of Clinical Dermatology, Studies of postmenopausal women indicate that estrogen
deprivation is associated with dryness, atrophy, fine
wrinkling, poor healing, epidermal thinning, declining dermal collagen content,
diminished skin moisture. The decrease was preventable by the use of hormone replacement therapy. The mean hydroxyproline content and therefore
the mean collagen content in the skin was found to be 48% greater in the treated than the untreated women, Conclusions: HRT with the mentioned regimes improved
parameters of skin ageing.
Osteoporosis: “Esterified
estrogens produced significant increases
in bone mineral density (lumbar spine, hip). 54.2%
greater spinal mineral. “1 of 4 white
women over the age of 60 had spinal compression fractures associated with
osteoporosis. One
woman of 5 will fracture a hip by the age of 90” Bone gain from long-term HRT.
Rheumatoid Arthritis: “Transdermal
HRT was well tolerated, increased well-being, reduced articular index and
increased lumbar spine bone density over a one year period in postmenopausal women with RA.”
Osteoarthritis:
When both incident and progressive radiographic knee OA
cases combined, current ERT use had a
60% decreased risk compared with never use
(OR 0.4, 95% CI 0.1-1.5).
Macular degeneration, age
related. HRT
resulted in a 36% reduction and other eye pathologies.
Sexual
Satisfaction: “HRT improves sexual function in the orgasm, lubrication and pain
domains …”
Mood
elevation and depression: “Numerous molecular and clinical
studies have implicated estrogen in modulating brain function including that
related to mood.” Fluctuations
in estrogen occur naturally throughout the
reproductive years and can be associated with disruptions in mood. Estrogen inhibits the re-uptake of the neural
transmitter serotonin.
10 Reasons for HRT:
Menopause Int. Vol. 16 No 1, pp.
44-46. Given the above, consider the
harm PhARMA has done to women.
RECOMMENDATIONS:
Compounded as a skin lotion, the
higher dose 2 mg or more of estradiol is
recommended because of the various positive health consequences of estrogen
increase with dose, plus progesterone. Skin
lotion absorption is about 10-20%. Excellent mail service is available from Medical
Plaza Pharmacy (949-586-6337, $105 for a 90 day supply). To spread the
lotion as far a possible, add a few drops of water to hand; this improves
absorption. After looking at a list of
over 50 formulas of HRT, compared to the older formulas such as in the Danish Study (sequential 2 mgs
estradiol and 1 mg of norethisterone), The current pill formulas are of too low
for me to recommend them. This lower dose is consistent recommendation of the
FDA for lower dose and shorter usage. Avoid Tibolone, which blocks estrogen. A patch is also available; however, it too is
a lower dose, and possible causes skin irritation.
|
|
|
|
Enter supporting content here
|
|
|